Matthew G. Manders - May 12, 2024 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Role
Director
Signature
/s/ Eric Halverson for Matt Manders, Attorney-in-Fact
Stock symbol
NEUE
Transactions as of
May 12, 2024
Transactions value $
$0
Form type
4
Date filed
5/14/2024, 09:09 PM
Previous filing
May 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEUE Common Stock Options Exercise $0 +4.76K +319.99% $0.00 6.24K May 12, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEUE Restricted Stock Units Options Exercise $0 -4.76K -100% $0.00* 0 May 12, 2024 Common Stock 4.76K Direct F1, F2
transaction NEUE Restricted Stock Units Award $0 +10.5K $0.00 10.5K May 13, 2024 Common Stock 10.5K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 All of these restricted stock units vested on May 12, 2024, one year from the grant date.
F3 All of these restricted stock units vest on May 13, 2025, one year from the grant date.